Discriminating Central Lung Cancer Tumors from Atelectasis Using Radiomics Analysis on Contrast-Free CT.

Abstract

Listen

Translate article

Accurate determination of tumor boundaries is crucial for staging and treating central lung cancer (CLC). This retrospective study aimed to evaluate the feasibility of contrast-free CT radiomics in discriminating CLC tumors from atelectasis. A total of 58 patients with CLC and associated lung atelectasis, corresponding to 58 tumors and 58 atelectasis regions, were included. Radiomics features were extracted from tumor and atelectasis areas using contrast-free CT images. The least absolute shrinkage and selection operator (LASSO) identified the most differential radiomics features. A logistic regression model (LR) was established and evaluated using 5-fold crossvalidation. Discrimination performance was assessed using the area under the ROC curve (AUC) and decision curve analysis (DCA). Additionally, the potential of visualizing and distinguishing tumors and atelectasis based on contrast-free CT was explored by comparing pixel-level radiomics features with contrast CT. A total of 1561 radiomics features were extracted, with 356 showing significant statistical differences between tumor and atelectasis. LASSO identified the 10 most differential radiomics features. The LR model trained with these features achieved an AUC of 0.94 (95% CI: 0.89-0.99), sensitivity of 0.88, and specificity of 0.89 in the training group, and an AUC of 0.81 (95% CI: 0.67-0.95), sensitivity of 0.78, and specificity of 0.65 in the validation group. DCA confirmed the clinical utility, and the radiomics feature square_firstorder_10Percentile showed good performance in distinguishing tumors from atelectasis, with consistency to contrast CT. Contrast-free CT radiomics can effectively discriminate CLC tumors from atelectasis.